Cancer Cytogenomics Microarray Consortium Aims to Set Standards for Arrays in Cancer Dx

The CCMC will next year carry out a multicenter validation study to demonstrate that the technology is reliable and reproducible enough for clinical use.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.